OREX

Orexigen Therapeutics, Inc. News Headlines

$5.87
*  
0.02
0.34%
Get OREX Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Orexigen Scripts Continue Impressive Track
1/21/2015 2:00:00 PM - Seeking Alpha


News Flash: The Endocrine Society Recommends Weight Loss Medications
1/21/2015 11:15:00 AM - Seeking Alpha


Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/16/2015 7:00:00 AM - Investopedia


A Deeper Look At Arena's Belviq Pricing
1/12/2015 3:02:00 PM - Seeking Alpha


Orexigen's Contrave May Have Pricing Competition
1/12/2015 9:13:00 AM - Seeking Alpha


Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring?
1/9/2015 2:49:00 PM - Seeking Alpha


Arena Investors Should Watch New Pricing Of Belviq Closely
1/9/2015 12:20:00 PM - Seeking Alpha


Anticipated FDA Approval Eludes Enteromedics
1/5/2015 12:21:00 PM - Seeking Alpha


Sell EnteroMedics And Step To The Sidelines
12/30/2014 12:25:00 PM - Seeking Alpha


Can High Priced Novo Nordisk Anti-Obesity Injection Make It?
12/29/2014 1:30:00 PM - Seeking Alpha


The Obesity Treatment Market Could Finally Achieve Some Of Its Potential In 2015
12/29/2014 1:24:00 PM - Seeking Alpha


Arena - Belviq Advertsing Closes Out Year With Big Push
12/29/2014 1:13:00 PM - Seeking Alpha


Is Vivus Headed Towards An Unfortunate Ending?
12/27/2014 8:27:00 AM - Seeking Alpha


4 Biotech Stocks that Doubled in 2014 - Analyst Blog
12/26/2014 9:00:00 AM - Investopedia


Novo Nordisk Enters Anti-Obesity Space With New FDA Approval
12/24/2014 7:46:00 AM - Seeking Alpha


Novo Nordisk's Saxenda Gets FDA Nod, Launch in 1H15 - Analyst Blog
12/24/2014 4:20:00 AM - Investopedia


Contrave Prescriptions Still Rising In A Down Week
12/22/2014 3:47:00 PM - Seeking Alpha


Orexigen - Contrave Script Numbers Remain Impressive
12/22/2014 3:31:00 PM - Seeking Alpha


Belviq Scripts Dip - Lack Of T.V. Ads Will Impact Next Numbers
12/22/2014 3:27:00 PM - Seeking Alpha


Orexigen Retreats After Positive News In Europe: 3 Things To Watch For
12/22/2014 3:18:00 PM - Seeking Alpha


Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog
12/22/2014 6:10:00 AM - Investopedia


JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Arena And Vivus Investors Need To Grasp Implications Of Orexigen
12/19/2014 2:22:00 PM - Seeking Alpha


Contrave Wins Approval Recommendation In Europe
12/19/2014 11:53:00 AM - Seeking Alpha